A learning curve in using organ retractor for single-incision laparoscopic right colectomy

• Published in: Scientific reports Vol. 11; no. 1; pp. 6546 - 10
• Main Authors: Shiraishi, Toshio, Tominaga, Tetsuro, Nonaka, Takashi, Hamada, Kiyoaki, Araki, Masato, Sumida, Yorihisa, Takeshita, Hiroaki, Fukuoka, Hidetoshi, To, Kazuo, Tanaka, Kenji, Sawai, Terumitsu, Nagayasu, Takeshi
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 22.03.2021; Nature Publishing Group UK; Nature Portfolio
• Subjects: Blood; Colon cancer; Colorectal cancer; Laparoscopy; Learning; Lymph nodes; Patients; Surgery; Surgical outcomes
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-86168-4

Single-incision laparoscopic surgery (SILS) has the potential to improve perioperative outcomes, including less postoperative pain, shorter operation time, less blood loss, and shorter hospital stay. However, SILS is technically difficult and needs a longer learning curve. Between April 2016 and September 2019, a total of 198 patients with clinical stage I/II right colon cancer underwent curative resection. In the case of the SILS approach, an organ retractor was usually used to overcome SILS-specific restrictions. The patients were divided into two groups by surgical approach: the SILS with organ retractor group (SILS-O, n = 33) and the conventional laparoscopic surgery group (LAC, n = 165). Clinical T status was significantly higher in the LAC group (p = 0.016). Operation time was shorter and blood loss was lower in the SILS-O group compared to the LAC group (117 vs. 197 min, p = 0.027; 10 vs. 25 mL, p = 0.024, respectively). In the SILS-O group, surgical outcomes including operation time, blood loss, number of retrieved lymph nodes, and postoperative complications were not significantly different between those performed by experts and by non-experts. Longer operation time (p = 0.041) was significantly associated with complications on univariate and multivariate analyses (odds ratio 2.514, 95%CI 1.047-6.035, p = 0.039). SILS-O was safe and feasible for right colon cancer. There is a potential to shorten the learning curve of SILS using an organ retractor.